Abstract
BackgroundDespite the expansion in the number of medications available in the treatment of juvenile idiopathic arthritis (JIA), inter-individual variation in therapeutic response and drug-associated toxicities continue to be a major...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
